Recondo, G., Mezquita, L., Facchinetti, F., Planchard, D., Gazzah, A., Bigot, L., . . . Friboulet, L. (2019). Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer. Clin Cancer Res.
Citação norma ChicagoRecondo, Gonzalo, et al. "Diverse Resistance Mechanisms to the Third-generation ALK Inhibitor Lorlatinib in ALK-rearranged Lung Cancer." Clin Cancer Res 2019.
MLA CitationRecondo, Gonzalo, et al. "Diverse Resistance Mechanisms to the Third-generation ALK Inhibitor Lorlatinib in ALK-rearranged Lung Cancer." Clin Cancer Res 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.